Commentary

Hundreds of trademark applications have been filed in the United States that include the word "entrepreneur." Many of the claimed owners of entrepreneur-formed trademarks have engaged in legal disputes over the scope and extent of each other's rights. Is the word "entrepreneur" capable of exclusive...

One of the great promises of embryonic stem cell research is being able to use human cloning to derive stem cells that carry genetic defects associated with myriad maladies, writes columnist Steve Clark, who explains recent scientific developments and raises some ethical questions....

Cancer therapies once again have become the driving force behind biotech industry growth, just as infectious diseases were a driving force for growth in the 1940s and 1950s, says columnist Michael Rosen. In this edition of Yer Biotech Blues, Rosen noted one similarity in the...

A depressingly small percentage - 17 percent to be precise - of surveyed physicians are using ambulatory electronic health records, which is surprising when you consider the U.S. devotes 16 percent of its national wealth to healthcare, says columnist and physician Barry Chaiken. In...

The Ninth Circuit Court says employers may no longer monitor their employees' text messages without permisison. The court has ruled that the Ontario, Calif. Police Department violated the Stored Communications Act and its employees' privacy rights by inquiring about the content of certain text messages....

In pre-IPO financial planning, technology and other entrepreneurs should concentrate on three major areas, according to attorney and WTN guest columnist Sverre Roang and Madison area wealth manager Chris Burque. In this second column on IPO financial planning, they advise entrepreneurs to focus on providing...

You can learn a lot from your children if you pay attention, but learn about modern innovation? Yes, especially because they are so technology savvy, says WTN columnist and innovation expert Tom Koulopoulos. In this edition of The Innovation Zone, Koulopoulos explores a typical father's...

With Wisconsin still trying to absorb recent events like the pending GM plant closing in Janesville and historic flooding, it's not a bad time to smell the roses - the biotech roses, according to columnist Tom Still. As Wisconsin biotech leaders prepare to invade the...